Benzinga | May 17, 2021 07:25AM EDT

Fortress Biotech Q1 EPS $(0.09) Beats $(0.16) Estimate, Sales $11.59M Miss $13.41M Estimate

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.16) by 43.75 percent. This is a 28.57 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $11.59 million which missed the analyst consensus estimate of $13.41 million by 13.59 percent. This is a 10.30 percent decrease over sales of $12.92 million the same period last year.